There is a symptom of menopause that women almost never bring up first, that doctors often forget to ask about, and that quietly erodes intimacy, comfort, and confidence for years. It is vaginal dryness, and the painful sex that so often comes with it. By some estimates, somewhere between half and seventy percent of women experience it after menopause. And yet research suggests only a small minority, often cited as fewer than one in ten, ever receive treatment for it.
That gap is heartbreaking, because this is one of the most treatable symptoms in all of menopause medicine. The reluctance to talk about it, on both sides of the exam room, is the main reason women suffer in silence. So let us talk about it plainly, the way a good clinician would if she had all the time in the world and you had given yourself permission to ask.
Why it happens: the estrogen connection
The tissues of the vulva, vagina, urethra, and bladder are rich in estrogen receptors. For decades, circulating estrogen keeps these tissues thick, elastic, well supplied with blood, and naturally lubricated. It also supports a population of healthy lactobacillus bacteria that keep the vaginal environment slightly acidic and resistant to infection.
When estrogen declines in perimenopause and falls sharply after menopause, all of that changes. The vaginal walls become thinner and less elastic. Blood flow drops. Natural lubrication decreases. The pH rises, which shifts the bacterial balance and makes urinary tract infections more likely. The clinical name for this whole cluster of changes is genitourinary syndrome of menopause, or GSM, a term adopted in 2014 by The Menopause Society and the International Society for the Study of Women's Sexual Health to replace the older and narrower phrase vaginal atrophy.
The single most important thing to understand about GSM is this: unlike hot flashes, it does not get better on its own. Hot flashes and night sweats tend to fade over a few years for most women. GSM is progressive. Left untreated, it usually worsens with time, because the underlying cause, low estrogen in those specific tissues, is permanent after menopause. This is why waiting it out is not a strategy that works here.
The symptoms, beyond just dryness
Women often describe GSM only as dryness, but the syndrome is broader than that. You may recognize one or several of these:
Dryness, burning, or itching in the vulva or vagina, present even when you are not thinking about sex. Painful intercourse, known medically as dyspareunia, which can range from mild friction to a tearing or burning sensation that makes intimacy something you start to avoid. Light bleeding or spotting after sex, caused by fragile tissue. Urinary symptoms, including urgency, frequency, discomfort with urination, and recurrent urinary tract infections, because the urethra and bladder neck are affected by the same estrogen loss. A general feeling of irritation or rawness, sometimes worse with exercise, tight clothing, or certain soaps.
None of this is a reflection of how attracted you are to your partner, how much you want intimacy, or anything you have done wrong. It is tissue biology, and tissue biology responds to treatment.
The good news: a full menu of treatments that work
Here is the part that too few women hear. There is a clear, well-studied ladder of options, from simple over-the-counter products to prescription therapies, and the great majority of women find substantial relief once they start. The right choice depends on how severe your symptoms are, whether intercourse is your main concern, and your personal medical history.
Step one: moisturizers and lubricants
These two products are not the same thing, and the difference matters. Vaginal moisturizers are used regularly, typically every two to three days, regardless of sexual activity. They cling to the vaginal lining and rehydrate the tissue over time. Hyaluronic acid based moisturizers have the best evidence among the non-hormonal options. Lubricants, by contrast, are used at the time of intercourse to reduce friction. Water based and silicone based lubricants both work well; avoid products with warming agents, high amounts of glycerin, or fragrances, which can irritate already sensitive tissue.
For mild GSM, consistent use of a good moisturizer plus a lubricant during sex is often enough. For moderate to severe symptoms, these products help but usually are not sufficient on their own, because they treat the surface without restoring the underlying tissue.
Step two: low-dose vaginal estrogen
This is the treatment that changes lives, and the one most surrounded by unnecessary fear. Vaginal estrogen comes as a cream, a small tablet or insert, or a soft flexible ring that releases hormone slowly over three months. It is applied directly to the tissue that needs it, which means it works exactly where the problem is.
The crucial fact: low-dose vaginal estrogen delivers a very small amount of hormone, and blood levels of estrogen generally stay within the normal postmenopausal range. This is fundamentally different from systemic hormone therapy taken for hot flashes. The Menopause Society and the American College of Obstetricians and Gynecologists both state that low-dose vaginal estrogen does not carry the same risk profile that women associate with oral hormones, and that the boxed warning currently on the labels is not well supported by the evidence for these local products. Most women using it do not even need a progestogen for endometrial protection at these doses, though your provider will make that call based on your situation.
Relief usually begins within a few weeks and becomes substantial by about twelve weeks of consistent use. Because GSM is chronic, vaginal estrogen is generally continued long term, since symptoms return when treatment stops.
Step three: other prescription options
If vaginal estrogen is not the right fit, there are alternatives. Vaginal DHEA (prasterone, sold as Intrarosa) is a nightly insert that the body converts locally into estrogen and testosterone within the vaginal tissue. Ospemifene (Osphena) is an oral pill, a selective estrogen receptor modulator, approved specifically for moderate to severe painful sex. For women who also have low libido as a separate concern, testosterone therapy is sometimes considered, though that addresses desire rather than the tissue itself.
Systemic hormone therapy taken for hot flashes does improve GSM for some women, but a meaningful number still need local treatment added on, because the dose reaching the vaginal tissue from a systemic patch or pill may not be enough.
A special note for breast cancer survivors
Women with a history of breast cancer are often told flatly that they can never use any form of estrogen, and are left with GSM that can be severe, especially on aromatase inhibitors. The reality is more nuanced. Non-hormonal moisturizers and lubricants are the first step. For women who do not get enough relief, low-dose vaginal estrogen may still be an option after a careful, individualized discussion between the patient, her oncologist, and her menopause provider. This is a conversation worth having rather than a door that should be automatically closed.
How to actually bring it up
If the hardest part is starting the conversation, here is a script that works: "I have vaginal dryness and sex has become painful. I would like to talk about treatment options, including vaginal estrogen." That one sentence tells your provider exactly what you need and signals that you are ready to discuss prescription therapy. You do not need to explain or apologize. This is a medical symptom, and you have every right to treatment for it.
If your current provider brushes the topic aside or seems uncomfortable, that is a reason to find someone who treats menopause regularly. A clinician who manages GSM all the time will not blink, and will likely have you feeling dramatically better within a few months.
"Vaginal dryness and painful sex are not the price of getting older, and they are not something you have to quietly accept. They are a treatable medical condition, and the treatments are safe, simple, and remarkably effective."
Medical Disclaimer: This article is for general educational purposes only and is not medical advice. Decisions about vaginal estrogen, hormone therapy, and other treatments are individual and should be made with a qualified healthcare provider who knows your full history. Always consult your provider before starting or changing any treatment.
Find a Provider Who Treats GSM and Vaginal Dryness
Vaginal estrogen, DHEA, and ospemifene all require a prescription. Search our directory for HRT-knowledgeable providers who treat genitourinary symptoms of menopause every day.
Find a Provider Near You